Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Diluted Average): 2018-2025

Historic Shares Outstanding (Diluted Average) for Fortress Biotech (FBIO) over the last 4 years, with Jun 2025 value amounting to $29.8 million.

  • Fortress Biotech's Shares Outstanding (Diluted Average) rose 62.82% to $29.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $29.8 million, marking a year-over-year increase of 62.82%. This contributed to the annual value of $20.8 million for FY2024, which is 156.25% up from last year.
  • Per Fortress Biotech's latest filing, its Shares Outstanding (Diluted Average) stood at $29.8 million for Q2 2025, which was up 12.76% from $26.5 million recorded in Q1 2025.
  • In the past 5 years, Fortress Biotech's Shares Outstanding (Diluted Average) registered a high of $101.9 million during Q1 2023, and its lowest value of $5.9 million during Q4 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $19.0 million (2024), whereas its average is $25.7 million.
  • Per our database at Business Quant, Fortress Biotech's Shares Outstanding (Diluted Average) tumbled by 92.75% in 2022 and then soared by 162.68% in 2024.
  • Fortress Biotech's Shares Outstanding (Diluted Average) (Quarterly) stood at $81.7 million in 2021, then plummeted by 92.75% to $5.9 million in 2022, then soared by 36.89% to $8.1 million in 2023, then soared by 156.25% to $20.8 million in 2024, then skyrocketed by 62.82% to $29.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $29.8 million in Q2 2025, compared to $26.5 million in Q1 2025 and $20.8 million in Q4 2024.